GLICARYL MV 40/0.3 MG (Voglibose (0.3mg) + Metformin (500mg) + Gliclazide (40mg))

Glicaryl-MV 40/0.3 mg Tablet is classified as an anti-diabetic medication, specifically designed for the management of type 2 diabetes mellitus in adults. This formulation combines multiple active ingredients that work synergistically to assist in regulating glucose levels in individuals diagnosed with diabetes. It is essential to take this medication alongside meals to enhance its therapeutic efficacy. Consistent daily intake at the same time is crucial for optimal results. The prescribing physician will determine the appropriate dosage, which may be adjusted based on periodic evaluations of blood sugar levels. It is important to continue using this medication even if you feel well or your glucose is under control, as discontinuing it without medical advice can lead to increased blood sugar levels, posing risks such as renal impairment, vision loss, nerve damage, and limb loss. A comprehensive treatment approach should also include dietary modifications, physical activity, and weight management as suggested by your healthcare provider since lifestyle factors are integral to effective diabetes management. A notable side effect associated with Glicaryl-MV 40/0.3 mg Tablet is the occurrence of low blood sugar (hypoglycemia). It is imperative to be familiar with the symptoms of hypoglycemia, including sweating, dizziness, headaches, and tremors. To minimize this risk, maintain regular meal patterns and have a readily available source of rapid glucose like sugary snacks or juice. Alcohol consumption is discouraged as it can exacerbate the risk of hypoglycemia. Additional side effects may encompass alterations in taste, gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal discomfort, along with headaches, swelling, blurred vision, and potential weight gain. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe renal or hepatic impairment. Prior to initiation, individuals with a history of heart disease should consult their healthcare provider. Regular monitoring of blood glucose, blood cell counts, and liver function tests may be advised throughout treatment.